Zhen Pan

Director/Miembro de la Junta en SHANGHAI GUIJIU CO.,LTD .

41 años

Consumer Services

Consumer Non-Durables

Health Technology

Perfil

Zhen Pan is currently working as a Director at Shanghai Guijiu Co., Ltd.
and as a Member-Supervisory Board at Hebei Yipin Pharmaceutical Co., Ltd.
He holds a Master's degree in Business Administration from Shanghai Jiao Tong University and an undergraduate degree from Shanghai University of Finance & Economics.

Cargos activos de Zhen Pan

Empresas	Cargo	Inicio
SHANGHAI GUIJIU CO.,LTD	Director/Miembro de la Junta	01/09/2021
Hebei Yipin Pharmaceutical Co., Ltd. Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China.	Director/Miembro de la Junta	01/03/2021

Todos los cargos activos de Zhen Pan

Formación de Zhen Pan.

Shanghai Jiao Tong University	Masters Business Admin
Shanghai University of Finance & Economics	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Zhen Pan.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
SHANGHAI GUIJIU CO.,LTD	Consumer Non-Durables

Empresas privadas	1
Hebei Yipin Pharmaceutical Co., Ltd. Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China.	Health Technology